United States Lupus Therapeutic Market Report 2017

January 2018 | 112 pages | ID: U291C744FB0EN
QYResearch

Abstracts

In this report, the United States Lupus Therapeutic market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:

• The West
• Southwest
• The Middle Atlantic
• New England
• The South
• The Midwest
• with sales (volume), revenue (value), market share and growth rate of Lupus Therapeutic in these regions, from 2012 to 2022 (forecast).

United States Lupus Therapeutic market competition by top manufacturers/players, with Lupus Therapeutic sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

• Roche
• GlaxoSmithKline
• Medlmmune
• Pfizer
• ADMA Biologics
• Amgen
• Anthera Pharma
• Bayer HealthCare
• Biogen
• Merck
• Novartis
• Shire
• Takeda Pharma
• Bristol-Myers Squibb

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

• Anti-inflammatory Drugs
• Corticosteroids
• Immunosuppressant Drugs
• Antimalarial Drugs
• Others

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

• Hospitals
• Clinics
• Others

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

United States Lupus Therapeutic Market Report 2017

1 LUPUS THERAPEUTIC OVERVIEW

1.1 Product Overview and Scope of Lupus Therapeutic
1.2 Classification of Lupus Therapeutic by Product Category
  1.2.1 United States Lupus Therapeutic Market Size (Sales Volume) Comparison by Type (2012-2022)
  1.2.2 United States Lupus Therapeutic Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
  1.2.3 Anti-inflammatory Drugs
  1.2.4 Corticosteroids
  1.2.5 Immunosuppressant Drugs
  1.2.6 Antimalarial Drugs
  1.2.7 Others
1.3 United States Lupus Therapeutic Market by Application/End Users
  1.3.1 United States Lupus Therapeutic Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
  1.3.2 Hospitals
  1.3.3 Clinics
  1.3.4 Others
1.4 United States Lupus Therapeutic Market by Region
  1.4.1 United States Lupus Therapeutic Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 The West Lupus Therapeutic Status and Prospect (2012-2022)
  1.4.3 Southwest Lupus Therapeutic Status and Prospect (2012-2022)
  1.4.4 The Middle Atlantic Lupus Therapeutic Status and Prospect (2012-2022)
  1.4.5 New England Lupus Therapeutic Status and Prospect (2012-2022)
  1.4.6 The South Lupus Therapeutic Status and Prospect (2012-2022)
  1.4.7 The Midwest Lupus Therapeutic Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Lupus Therapeutic (2012-2022)
  1.5.1 United States Lupus Therapeutic Sales and Growth Rate (2012-2022)
  1.5.2 United States Lupus Therapeutic Revenue and Growth Rate (2012-2022)

2 UNITED STATES LUPUS THERAPEUTIC MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Lupus Therapeutic Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Lupus Therapeutic Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Lupus Therapeutic Average Price by Players/Suppliers (2012-2017)
2.4 United States Lupus Therapeutic Market Competitive Situation and Trends
  2.4.1 United States Lupus Therapeutic Market Concentration Rate
  2.4.2 United States Lupus Therapeutic Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Lupus Therapeutic Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES LUPUS THERAPEUTIC SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2012-2017)

3.1 United States Lupus Therapeutic Sales and Market Share by Region (2012-2017)
3.2 United States Lupus Therapeutic Revenue and Market Share by Region (2012-2017)
3.3 United States Lupus Therapeutic Price by Region (2012-2017)

4 UNITED STATES LUPUS THERAPEUTIC SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2012-2017)

4.1 United States Lupus Therapeutic Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Lupus Therapeutic Revenue and Market Share by Type (2012-2017)
4.3 United States Lupus Therapeutic Price by Type (2012-2017)
4.4 United States Lupus Therapeutic Sales Growth Rate by Type (2012-2017)

5 UNITED STATES LUPUS THERAPEUTIC SALES (VOLUME) BY APPLICATION (2012-2017)

5.1 United States Lupus Therapeutic Sales and Market Share by Application (2012-2017)
5.2 United States Lupus Therapeutic Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 UNITED STATES LUPUS THERAPEUTIC PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 Roche
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Lupus Therapeutic Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Roche Lupus Therapeutic Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 GlaxoSmithKline
  6.2.2 Lupus Therapeutic Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 GlaxoSmithKline Lupus Therapeutic Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Medlmmune
  6.3.2 Lupus Therapeutic Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Medlmmune Lupus Therapeutic Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Pfizer
  6.4.2 Lupus Therapeutic Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Pfizer Lupus Therapeutic Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 ADMA Biologics
  6.5.2 Lupus Therapeutic Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 ADMA Biologics Lupus Therapeutic Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Amgen
  6.6.2 Lupus Therapeutic Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Amgen Lupus Therapeutic Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Anthera Pharma
  6.7.2 Lupus Therapeutic Product Category, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Anthera Pharma Lupus Therapeutic Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 Bayer HealthCare
  6.8.2 Lupus Therapeutic Product Category, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Bayer HealthCare Lupus Therapeutic Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview
6.9 Biogen
  6.9.2 Lupus Therapeutic Product Category, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Biogen Lupus Therapeutic Sales, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Main Business/Business Overview
6.10 Merck
  6.10.2 Lupus Therapeutic Product Category, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 Merck Lupus Therapeutic Sales, Revenue, Price and Gross Margin (2012-2017)
  6.10.4 Main Business/Business Overview
6.11 Novartis
6.12 Shire
6.13 Takeda Pharma
6.14 Bristol-Myers Squibb

7 LUPUS THERAPEUTIC MANUFACTURING COST ANALYSIS

7.1 Lupus Therapeutic Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Lupus Therapeutic

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Lupus Therapeutic Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Lupus Therapeutic Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES LUPUS THERAPEUTIC MARKET SIZE (VALUE AND VOLUME) FORECAST (2017-2022)

11.1 United States Lupus Therapeutic Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Lupus Therapeutic Sales Volume Forecast by Type (2017-2022)
11.3 United States Lupus Therapeutic Sales Volume Forecast by Application (2017-2022)
11.4 United States Lupus Therapeutic Sales Volume Forecast by Region (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Lupus Therapeutic
Figure United States Lupus Therapeutic Market Size (K Units) by Type (2012-2022)
Figure United States Lupus Therapeutic Sales Volume Market Share by Type (Product Category) in 2016
Figure Anti-inflammatory Drugs Product Picture
Figure Corticosteroids Product Picture
Figure Immunosuppressant Drugs Product Picture
Figure Antimalarial Drugs Product Picture
Figure Others Product Picture
Figure United States Lupus Therapeutic Market Size (K Units) by Application (2012-2022)
Figure United States Sales Market Share of Lupus Therapeutic by Application in 2016
Figure Hospitals Examples
Table Key Downstream Customer in Hospitals
Figure Clinics Examples
Table Key Downstream Customer in Clinics
Figure Others Examples
Table Key Downstream Customer in Others
Figure United States Lupus Therapeutic Market Size (Million USD) by Region (2012-2022)
Figure The West Lupus Therapeutic Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Lupus Therapeutic Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Lupus Therapeutic Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Lupus Therapeutic Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Lupus Therapeutic Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Lupus Therapeutic Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Lupus Therapeutic Sales (K Units) and Growth Rate (2012-2022)
Figure United States Lupus Therapeutic Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Lupus Therapeutic Market Major Players Product Sales Volume (K Units) (2012-2017)
Table United States Lupus Therapeutic Sales (K Units) of Key Players/Suppliers (2012-2017)
Table United States Lupus Therapeutic Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Lupus Therapeutic Sales Share by Players/Suppliers
Figure 2017 United States Lupus Therapeutic Sales Share by Players/Suppliers
Figure United States Lupus Therapeutic Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Lupus Therapeutic Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Lupus Therapeutic Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Lupus Therapeutic Revenue Share by Players/Suppliers
Figure 2017 United States Lupus Therapeutic Revenue Share by Players/Suppliers
Table United States Market Lupus Therapeutic Average Price (USD/Unit) of Key Players/Suppliers (2012-2017)
Figure United States Market Lupus Therapeutic Average Price (USD/Unit) of Key Players/Suppliers in 2016
Figure United States Lupus Therapeutic Market Share of Top 3 Players/Suppliers
Figure United States Lupus Therapeutic Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Lupus Therapeutic Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Lupus Therapeutic Product Category
Table United States Lupus Therapeutic Sales (K Units) by Region (2012-2017)
Table United States Lupus Therapeutic Sales Share by Region (2012-2017)
Figure United States Lupus Therapeutic Sales Share by Region (2012-2017)
Figure United States Lupus Therapeutic Sales Market Share by Region in 2016
Table United States Lupus Therapeutic Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Lupus Therapeutic Revenue Share by Region (2012-2017)
Figure United States Lupus Therapeutic Revenue Market Share by Region (2012-2017)
Figure United States Lupus Therapeutic Revenue Market Share by Region in 2016
Table United States Lupus Therapeutic Price (USD/Unit) by Region (2012-2017)
Table United States Lupus Therapeutic Sales (K Units) by Type (2012-2017)
Table United States Lupus Therapeutic Sales Share by Type (2012-2017)
Figure United States Lupus Therapeutic Sales Share by Type (2012-2017)
Figure United States Lupus Therapeutic Sales Market Share by Type in 2016
Table United States Lupus Therapeutic Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Lupus Therapeutic Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Lupus Therapeutic by Type (2012-2017)
Figure Revenue Market Share of Lupus Therapeutic by Type in 2016
Table United States Lupus Therapeutic Price (USD/Unit) by Types (2012-2017)
Figure United States Lupus Therapeutic Sales Growth Rate by Type (2012-2017)
Table United States Lupus Therapeutic Sales (K Units) by Application (2012-2017)
Table United States Lupus Therapeutic Sales Market Share by Application (2012-2017)
Figure United States Lupus Therapeutic Sales Market Share by Application (2012-2017)
Figure United States Lupus Therapeutic Sales Market Share by Application in 2016
Table United States Lupus Therapeutic Sales Growth Rate by Application (2012-2017)
Figure United States Lupus Therapeutic Sales Growth Rate by Application (2012-2017)
Table Roche Basic Information List
Table Roche Lupus Therapeutic Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Roche Lupus Therapeutic Sales Growth Rate (2012-2017)
Figure Roche Lupus Therapeutic Sales Market Share in United States (2012-2017)
Figure Roche Lupus Therapeutic Revenue Market Share in United States (2012-2017)
Table GlaxoSmithKline Basic Information List
Table GlaxoSmithKline Lupus Therapeutic Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure GlaxoSmithKline Lupus Therapeutic Sales Growth Rate (2012-2017)
Figure GlaxoSmithKline Lupus Therapeutic Sales Market Share in United States (2012-2017)
Figure GlaxoSmithKline Lupus Therapeutic Revenue Market Share in United States (2012-2017)
Table Medlmmune Basic Information List
Table Medlmmune Lupus Therapeutic Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Medlmmune Lupus Therapeutic Sales Growth Rate (2012-2017)
Figure Medlmmune Lupus Therapeutic Sales Market Share in United States (2012-2017)
Figure Medlmmune Lupus Therapeutic Revenue Market Share in United States (2012-2017)
Table Pfizer Basic Information List
Table Pfizer Lupus Therapeutic Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Pfizer Lupus Therapeutic Sales Growth Rate (2012-2017)
Figure Pfizer Lupus Therapeutic Sales Market Share in United States (2012-2017)
Figure Pfizer Lupus Therapeutic Revenue Market Share in United States (2012-2017)
Table ADMA Biologics Basic Information List
Table ADMA Biologics Lupus Therapeutic Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure ADMA Biologics Lupus Therapeutic Sales Growth Rate (2012-2017)
Figure ADMA Biologics Lupus Therapeutic Sales Market Share in United States (2012-2017)
Figure ADMA Biologics Lupus Therapeutic Revenue Market Share in United States (2012-2017)
Table Amgen Basic Information List
Table Amgen Lupus Therapeutic Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Amgen Lupus Therapeutic Sales Growth Rate (2012-2017)
Figure Amgen Lupus Therapeutic Sales Market Share in United States (2012-2017)
Figure Amgen Lupus Therapeutic Revenue Market Share in United States (2012-2017)
Table Anthera Pharma Basic Information List
Table Anthera Pharma Lupus Therapeutic Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Anthera Pharma Lupus Therapeutic Sales Growth Rate (2012-2017)
Figure Anthera Pharma Lupus Therapeutic Sales Market Share in United States (2012-2017)
Figure Anthera Pharma Lupus Therapeutic Revenue Market Share in United States (2012-2017)
Table Bayer HealthCare Basic Information List
Table Bayer HealthCare Lupus Therapeutic Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Bayer HealthCare Lupus Therapeutic Sales Growth Rate (2012-2017)
Figure Bayer HealthCare Lupus Therapeutic Sales Market Share in United States (2012-2017)
Figure Bayer HealthCare Lupus Therapeutic Revenue Market Share in United States (2012-2017)
Table Biogen Basic Information List
Table Biogen Lupus Therapeutic Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Biogen Lupus Therapeutic Sales Growth Rate (2012-2017)
Figure Biogen Lupus Therapeutic Sales Market Share in United States (2012-2017)
Figure Biogen Lupus Therapeutic Revenue Market Share in United States (2012-2017)
Table Merck Basic Information List
Table Merck Lupus Therapeutic Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Merck Lupus Therapeutic Sales Growth Rate (2012-2017)
Figure Merck Lupus Therapeutic Sales Market Share in United States (2012-2017)
Figure Merck Lupus Therapeutic Revenue Market Share in United States (2012-2017)
Table Novartis Basic Information List
Table Shire Basic Information List
Table Takeda Pharma Basic Information List
Table Bristol-Myers Squibb Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Lupus Therapeutic
Figure Manufacturing Process Analysis of Lupus Therapeutic
Figure Lupus Therapeutic Industrial Chain Analysis
Table Raw Materials Sources of Lupus Therapeutic Major Players/Suppliers in 2016
Table Major Buyers of Lupus Therapeutic
Table Distributors/Traders List
Figure United States Lupus Therapeutic Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure United States Lupus Therapeutic Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Lupus Therapeutic Price (USD/Unit) Trend Forecast (2017-2022)
Table United States Lupus Therapeutic Sales Volume (K Units) Forecast by Type (2017-2022)
Figure United States Lupus Therapeutic Sales Volume (K Units) Forecast by Type (2017-2022)
Figure United States Lupus Therapeutic Sales Volume (K Units) Forecast by Type in 2022
Table United States Lupus Therapeutic Sales Volume (K Units) Forecast by Application (2017-2022)
Figure United States Lupus Therapeutic Sales Volume (K Units) Forecast by Application (2017-2022)
Figure United States Lupus Therapeutic Sales Volume (K Units) Forecast by Application in 2022
Table United States Lupus Therapeutic Sales Volume (K Units) Forecast by Region (2017-2022)
Table United States Lupus Therapeutic Sales Volume Share Forecast by Region (2017-2022)
Figure United States Lupus Therapeutic Sales Volume Share Forecast by Region (2017-2022)
Figure United States Lupus Therapeutic Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources